Introduction:
Fujifilm plans to invest US$1.2 billion to open state-of-the-art manufacturing hubs in the United States.
Features:
The expansion will significantly enhance the large-scale production capacity of the global network through its manufacturing hubs in the United States and Europe.
This expansion not only allows for the accommodation of new projects but also positions the site to become one of the largest cell culture biopharmaceutical CDMO facilities in North America upon completion.
As part of the initial investment, the upcoming expansion in large-scale cell culture facilities will include an additional 8 x 20,000 litres (L) mammalian cell culture bioreactors by 2028, supplementing the already planned 8 x 20,000 L capacity for bulk drug substance.
The investment aims to create 680 more jobs by 2031, bringing the total number of new, highly skilled local positions to 1400.
Specifications:
Name Fujifilm
Type Expansion
Budget US$1.2 billion
Year 2031
